Clinical Trial Update: Piclidenoson for Treatment of COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for piclidenoson in treating COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Piclidenoson (Piclidenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: COVID-19, Coronavirus Infection | Phase 2 | Status: COMPLETED